Mesenchymal Tumor: Clinical Trials

3 trials for Mesenchymal Tumor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 withdrawn. 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Withdrawn 1
Phase 11Completed 1

Follow Mesenchymal Tumor: new trials by email Literature Review of Mesenchymal Tumor trials Research Report on Mesenchymal Tumor

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of a New EUS Guided Biopsy Needle (SharkCore) Comparing to Standard EUS Needle (ProCore)
EUS-FNB with ProCore needle, EUS-FNB with SharkCore needle, ProCore needle - Mesenchymal Tumor, Autoimmune Pancreatitis
Phase 2WithdrawnJohns Hopkins University2016-04-012017-05-15
Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors
PegLiposomal Doxorubicin, Carboplatin - Mesenchymal Tumor, Carcinosarcoma
Phase 2CompletedAGO Study Group412008-06-012017-02-14
High-Dose Proton/Photon RT + Surgery of Sarcomas of the Thoracic, Lumbar Spine/Sacrum
Proton Beam Radiation, Photon Beam Radiation, Interoperative radiation - Mesenchymal Tumor
Phase 1 / Phase 2CompletedMassachusetts General Hospital501999-05-012017-02-03

Narrower conditions

Autoimmune Pancreatitis (1)  ·  Carcinosarcoma (1)  ·  Leiomyosarcoma (1)  ·  Lymphoma (1)

Broader conditions

Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Autoimmune Diseases (1)  ·  Chronic Disease (1)  ·  Digestive System Diseases (1)  ·  Disease Attributes (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Lymphatic Diseases (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms, Complex and Mixed (1)  ·  Neoplasms, Connective and Soft Tissue (1)  ·  Neoplasms, Muscle Tissue (1)  ·  Pancreatic Diseases (1)

Interventions

Carboplatin (1)  ·  Proton Therapy (1)  ·  liposomal doxorubicin (1)

Sponsors

AGO Study Group (1)  ·  Johns Hopkins University (1)  ·  Massachusetts General Hospital (1)

Countries

United States (2)  ·  Germany (1)

Top investigators

Mouen Khashab, MD (1)  ·  Philipp Harter, MD (1)  ·  Thomas F. DeLaney, MD (1)